Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–17 of 17 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT07511283
- Conditions
- Calcific Uremic Arteriolopathy, Calcinosis, Calciphylaxis, +19 more
- Locations
-
- Odense University Hospital Odense, Denmark
NCT04592640
- Conditions
- Calcific Uremic Arteriolopathy, Calcinosis, Calciphylaxis, +20 more
- Locations
-
- The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital Nanjing, Jiangsu, China
NCT04654000
- Conditions
- Calcinosis, Calciphylaxis, Calcium Metabolism Disorders, +18 more
- Locations
-
- CHU d'Angers Angers, France
- CHU d'Arras Arras, France
- CHU d'Auxerre Auxerre, France
- CHU de Besançon, Hôpital Jean Minjoz Besançon, France
NCT05018221
- Conditions
- Calcinosis, Calciphylaxis, Calcium Metabolism Disorders, +2 more
- Locations
-
- Concord Repatriation General Hospital Concord, New South Wales, Australia
- St George Hospital Kogarah, New South Wales, Australia
- Liverpool Hospital Liverpool, New South Wales, Australia
- John Hunter Hospital New Lambton Heights, New South Wales, Australia
NCT02280733
- Conditions
- Arterial Occlusive Diseases, Arterial Ulcers, Arteriosclerosis, +44 more
- Locations
-
- US Wound Registry The Woodlands, Texas, United States
Partners Calciphylaxis Biobank
NCT03032835
- Conditions
- Calcific Uremic Arteriolopathy, Calcinosis, Calciphylaxis, +18 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
National Registry of Rare Kidney Diseases
NCT06065852
- Conditions
- AH Amyloidosis, AHL Amyloidosis, AL Amyloidosis, +207 more
- Locations
-
- Zoe Plummer Bristol, South West, United Kingdom
Anti-Interleukin-6 (IL6) in Calciphylaxis
NCT07708038
- Conditions
- Calcinosis, Calciphylaxis, Calcium Metabolism Disorders, +15 more
- Locations
-
- Boston Medical Center Boston, Massachusetts, United States
Emerging Indications for Hyperbaric Oxygen Treatment
NCT07240649
- Conditions
- Acute COVID-19, Anastomosis, Leaking, Arterial Occlusive Diseases, +137 more
- Locations
-
Not specified
Study of EPN-701 for the Treatment of Calciphylaxis
NCT07583745
- Conditions
- Calcinosis, Calciphylaxis, Calcium Metabolism Disorders, +2 more
- Locations
-
- Renal Associates Boston, Massachusetts, United States
NCT02854046
- Conditions
- Calcinosis, Calciphylaxis, Calcium Metabolism Disorders, +2 more
- Locations
-
- CHU de Nantes Nantes, France
NCT06283589
- Conditions
- Calcinosis, Calcinosis Cutis, Calciphylaxis, +19 more
- Locations
-
- South Florida Nephrology Research Coral Springs, Florida, United States
- Elixia Health Hollywood, Florida, United States
NCT04195906
- Conditions
- Calcific Uremic Arteriolopathy, Calcinosis, Calciphylaxis, +17 more
- Locations
-
- AKDHC Medical Research Services Phoenix, Arizona, United States
- California Institute of Renal Research El Centro, California, United States
- California Institute of Renal Research Escondido, California, United States
- Kidney Disease Medical Group Glendale, California, United States
NCT01578382
- Conditions
- Calcinosis, Calciphylaxis, Calcium Metabolism Disorders, +9 more
- Locations
-
- Department of Dermatology, University Hospital of Zurich Zurich, Canton of Zurich, Switzerland
NCT02278692
- Conditions
- Calcific Uremic Arteriolopathy, Calcinosis, Calciphylaxis, +16 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT02790073
- Conditions
- Calcific Uremic Arteriolopathy, Calcinosis, Calciphylaxis, +17 more
- Locations
-
- Fresenius Medical Services Waltham, Massachusetts, United States
- Davita Clinical Research Minneapolis, Minnesota, United States
- Salford Royal Hospital Salford, United Kingdom
NCT01289626
- Conditions
- Calcinosis, Calciphylaxis, Calcium Metabolism Disorders, +2 more
- Locations
-
- University of Wisconsin Hospitals Madison, Wisconsin, United States